BCAX
Bicara Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.47
+4.11%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-39.5%
Return on equity
-36.2%
Return on assets
-43.0%
Return on invested capital
0.00x
Asset turnover
-$134.8M
Cash from operations
$7.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026